is an csscntial cofactor for production of nitric oxide (NO) by NO synthase (NOS). Nitric oxide (NO) is an important signaling mo!ecu!e for the regulation of vita! functions such as vascular tone, neurotransmission and immune surveiüance. Accumu!ated evidences show that although NOS mainly re!eases NO under nonnal conditions, NOS also produces Superoxide anion and hydrogen peroxide when BH4 is decreased, suggesting the possibility that NOS is a source of reactive oxygen species (ROS) under pathological conditions. In fact, supplementation of BH4 restores NO production and availability in various diseases including hyperlipidemia, diabetes, hypertension and ischemia-reperfusion. Moreover, recent studies show that administration of BII4 protects tissues against ischemia-reperfusion injuiy in heart, stomach and liver. Oxidative stress is a common mechanism underlying the development of vascular diseases and reperfusion injury. Regulation of BH4 levels under oxidative stress is important to understand the role of BH4 on the development of vascular diseases and reperfusion injury. We recently described that oxidative stress transiently decreased BH4 levels, and then markedly increased its levels in vascular endothelial cells. Supplementation of BH4 appears to be important therapeutic strategies in vascular diseases and reperfusion injury, and induction of BH4 synthesis may endogenous defense system against oxidative stress-mediated cardiovascular diseases.
Introduction
ROS by NOS in the presence of suboptimal concentrations of BH4 may lead to cytotoxicity. It is believed Nitric oxide (NO) that regulates vital functions such that BH4 levels is decreased during cardiovascular disas vascular tone, neurotransmission and immune sureases, because it is one of the most potent naturally veillance, is synthesized by the conversion of L-argioccurring reducing agents, and oxidative stress is a nine to L-citrulline by NO synthase (NOS). The reduccommon mechanism to develop cardiovascular distion of NO availability and/or production is an early eases ineluding arteriosclerosis, diabetic vascular event in vascular dysfunction during hypercholesinjury and ischemia-reperfusion injury. Thus, it is posterolemia, diabetes, hypertension and cigarette smoksible that dysfunction of NOS with reduction of BH4 ing, and leads to cardiovascular diseases (1, 2) . NOS may be an important factor in the development of requires 5,6,7,8-tetrahydrobiopterin (BH4) as a critical many circulatory diseases. In fact, administration of cofactor (3) (4) (5) (6) . Importantly, accumulated evidences BH4 restored NO availability in various cardiovascular have shown that NOS produces reactive oxygen diseases (15) (16) (17) (18) . However, changes in BH4 levels species (ROS) instead of NO when BH4 and/or L-argiunder pathological conditions are largely unknown.
nine, a substrate of NOS, are decreased (7) (8) (9) (10) . NO Regulation of BH4 levels under pathological condireacts with ROS such as Superoxide anion and hydrolions is important to understand the underlying mechagen peroxide to form peroxynitrite, singlet oxygen and nisms to develop cardiovascular diseases. There are hydroxyl radical, which are more toxic species (11-few reports showing that the effect of ROS on the reg-ficial effects of BII4 against cardiovascular diseases and the regulation of changes in BH4 levcl during oxidative stress will be discussed.
Dysfunction q/'NOS and vascular injury
There arc three isoforins of NOS, including constitutivc foims from neuronal cells (NÜS i or nNOS) and endothelial cells (NOS III or eNOS), and an inducible form from macrophages, neutrophils and smooth muscle cells (NOS 11 or iNOS). BH4 is an essential cofactor for NO production by all Ihree isoforms of NOS (3) (4) (5) (6) . All isoforms of NOS only active as homodimer. and thc stabilization and maintenance of NOS dimmer are dependent on BH4 (9) . BH4 also plays a crucial role in the multistep oxidation of arginine for gcncration of NO, as shown in review of Werner et al. (9) . Importantly, in the absence of BH4, NOS not only decreases the production of BH4, but also increases Superoxide anion and hydrogen peroxide in purified NOS (7) (8) (9) (10) . NO has been shown to react with Superoxide anion and hydrogen peroxide to produce highly toxic spccics such as peroxynitrite and the hydroxyl radical (11) (12) (13) (14) . The simultaneous production of NO and ROS by NOS may lead to vascular injury.
A reduccd bioavilability of NO is thc early event in the developing of cardiovascular diseases in hypcrcholesterolemia, hypertension, diabetes and cigarette Smoking (1, 2). Oxidative stress is the common mcchanism leading to vascular diseases. Since BH4 is onc of the most potent naturally occurring reducing agents, it is bclicvcd that BII4 levels are decrcased during vascular diseases. In fact, there are some reports showing that reduction of BH4 levels in vascular during various diseases such as hyperlipidemia (22) , ovariectomy (23) and hypertension (24) , although the mechanisms responsible for thc loss of BH4 arc largely unknown. Moreover, recent studies showing that the administration of BH4 restored vascular endothelial cell function in human and various experimental models (16. 17, 25-28) . Thus, thc loss of BII4 is likely to bc an important mechanism for dysfunction of vascular endothelial cell under pathological conditions. In insulin-rcsistant rat. moreover, it has been shown that impaired vasodilation is paralleied by a decreased BH^ to 7,8-dihydrobiopterin (BHj) ratio (BH4/BH2) ( 17, 29) . Not only depletion of BH4 but also BH4/BH2 ratio appcars to be important factor for the regulation of NOS function. Targeting of BH4 may be important strategies to prevent thc developing of vascular diseases.
Protective cffect of BH^ against
ischemia-reperfusion inJury Ischemia-rcperfusion injury is a common clinical problcm that occurs in various situations including coronary artery vasospasm, thrombolytic therapy. coronary angioplasty, and vascular or heart surgery. A variety of mechanisms are implicated in ischemiarepcrfusion injury, such as intracellular Ca^ overload, generation of ROS, the inflammation with neutrophil Infiltration, and endothelial dysfunction.
Administration of BH4 has been shown to reduce ischemia-reperfusion injury in various model including heart, stomach and lung (28, (30) (31) (32) (33) (34) . TJie protective effect of BH4 appears to bc mediated by the increased NO production, since the cffect was blocked by the cotreatment with NOS Inhibitor, and BH4 increases the production of NOx and cGMP during ischemia-reperfusion (30, 31, 34) . Although NO has been shown to attenuatc ischcmia-reperfusion injury (35) , hypoxiareoxygenation injury (36) and ROS-induced cytotoxicity (37) (38) (39) , there have been also many reports of the toxic effects of NO in pathologic conditions, including ischemia-reperfusion, inflammation and diabetes mellitus (40) (41) (42) . In fact, a large amount of NO induces cell death in various types of cells including vascular endothelial cells (43) . NO produced by NOS III is likely to be cardioprotective, whcreas the exccss amount of NO produccd by NOS II may be detrimental to the tissucs.
Although the mechanisms of protective effcct of BH4 through increased NO production against ischemia-reperfusion injury is still unclear, NO has variety of function to reduce ischemia-reperfusion injury in cardiovascular system, including vasodilation, anti-aggregation of platelet, Inhibition of leukocyte activation, decrease in O2 consumption during ischemia. Ticfcnbacher er al. (30) described that administration of sepiapterin, a substrate of salvage pathway of BH4 synthesis, attenuated postischemic injury through the Stimulation of NO synthesis in the rat heart, and the reduction of neutrophil extravasation is implicated in its protectivc effect. It is well known that extravasation of neutrophils is important for the development of rcperfusion injury by releasing ROS, proteases and pro-inflammatory cytokines that further amplify thc Infiltration of neutrophils (53) (54) (55) . Moreo\er. NO has been shown to inhibit the expression of lCAM-1, which is an important molecule for adhesion of neutrophils to vascular endothelial cells (56) .
We recently found that the protective cffect of BH4 against myocardial infarction is abolished by specific Inhibitors of mitochondrial ATP-dependent K' Channels (mitoK;\jp Channels) and NOS (unpublished rcsults). Recent studies suggcstcd that opcning of mitoKa^xp Channels have cardioprotection (44, 45) . Opcning of mitoK^^p Channels prevents decreasc in ATP levels during ischemia and significantly recovers ATP levels during reperfusion in cardiomyocyte (57) . Although the mechanisms for protection of mitochonPteridines/Vol. I 7/Na. 1 (46) suggested that Larginine, a substrate of NOS, might exert myocardial cell protection via opening of mitoKATp. Furthermorc, it was reported that NO directly activates mitoK^jp Channels in rabbit cardiomyocytes (47) . Accordingly, it might be possibie that BH4 appears to exert, at least a part, cardioprotection through NO-mitoK^^^yp Channels pathway. The speculative mechanisms of the protective effect of BH4 against myocardial infarction are shown in figure 1. BH4 may be useftii substance to treat ischemic diseases such as myocardial infarction. because the cardioprotection by exogenous BH4 was observed in not only preischemic treatment but also postischemic treatment.
Changes in BH^ levels under oxidative stress
The regulation of BH4 levels under pathoiogical conditions is important to understand the underlying mechanisms to develop cardiovascular diseases. Despite the beneficial effect of supplemented BH4, only few reports are available showing that BH4 levels are decreased in tissues (19) (20) (21) . It is believed that oxidative stress is the common mechanism underlying the development of vascular diseases and ischemiareperfusion injury. BH4 is easily oxidized by peroxynitrite, hydroxyl radical and Superoxide anion but not by hydrogen peroxide in a cell-free assay system (21, 48, 49) . Actually, addition of ROS to vascular endothelial cells transiently decreased BH4 levels (21) . The Observation was consistent with the hypothesis that Bi44 levels are decreased under pathologic conditions with oxidative stress in vascular endothelial cells. However, the BH4 levels after treatment with ROS then increased with prolonged incubation in mouse brain microvascular endothelial cells (19) . The biosynthesis of BH4 can occur via a de novo pathway from guanosine triphosphate (üfP). in which the enzyme GTP-cyclohydrolase 1 (GTPCH) catalyzes the rate-limiting Step, or via a salvage pathway that utilizes sepiaptcrin during an intermediate step (50, 51) . Addition of ROS or reactive nitrogen species (RNS) increased the expression of GTPCH, and the increase in BH4 levels were inhibited by GTPCH inhibitor, suggestmg that ROS and RNS increased BH4 levels by the induction of GTPCH. On the other hand, more recently, Kalivendi et al. (20) reported that hydrogen peroxide continuously produced by glucose-oxidase decreased BH4 despite the increase in GTPCH protein levels. They discussed the implication of co-induction of GTPCH-feedback regulation protein (GFRP). However, we found that treatment with hydrogen peroxide decreased GFRP mRNA levels (52) . The discrepancy is dependent on the experimental conditions, types of cells and/or incubation time. The more detail studies will be needed to determine the efFects of ROS and RNS on the changes in BH4 levels in isolated tissues and/or in vivo.
Conclusions
Dysfunction of vascular endothelial cells, especial-Shimizu S. et a/. \ Beneficial Role of Tctrahydrobiopterin ly, a reduced bioavailability of NO is an carly event in various vascular diseases. BH4 seems to be one of the most important targets of vascular diseases. The administration of BH4 may be a rational therapeutic targel in vascular diseases. Moreovcr, BH4 has a beneficial effeet against ischemia-reperfusion injury. Although BH4 levels undcr pathologicai conditions remain to be clarified, oxidative stress appears to induce BH4 synthesis. To understand the role of BH4 in various vascular diseases and ischemia-reperfusion, the future studies will be required to cxamine the changes in BH4 levels under pathologic conditions with in vivo.
